This book covers the use of nanomedicine in the delivery of neuroprotective agents, including pharmacological drugs, stem cells, neurotrophic factors, monoclonal antibodies
and enzymes to induce greater beneficial effects in neurologic diseases. Thus, the main purpose of the book is to explore the delivery of drugs either alone or in combination with stem cells to enhance neuroprotection in neurological diseases. Brain pathology associated with acute trauma such as head injury and brain blast injury can also be managed using novel treatment strategies. In addition, emphasis is made that standard patterns of brain pathology may be complicated with multiple comorbidity factors where one agent alone is not sufficient to induce brain protection. Enzymes and antibodies may help in combination and enhance the efficacy when administered through nanotechnology. Progress in
Nanomedicine in Neurologic Diseases
will encourage further research in the field of neuroprotection, brain injury, neurodegenerative diseases, neuropharmacology, neuropathology, and neurology. Students and researchers along with policy makers, teachers and health care professionals may also benefit from the findings of the book for enhanced patients care.
Reihe
Auflage
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Illustrationen
1
39 farbige Abbildungen, 1 s/w Abbildung
XV, 418 p. 40 illus., 39 illus. in color.
Maße
Höhe: 23.5 cm
Breite: 15.5 cm
Gewicht
ISBN-13
978-3-031-32996-8 (9783031329968)
DOI
10.1007/978-3-031-32997-5
Schweitzer Klassifikation
Hari S. Sharma, PhD,
is Professor of Neurobiology, Department of Surgical Sciences, Anesthesiology and Intensive Care at Uppsala University, Uppsala, Sweden
Aruna Sharma, MD,
is in the Department of Surgical Sciences, Anesthesiology and Intensive Care at Uppsala University, Uppsala, Sweden
